Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices
Open Access
- 18 May 2022
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (7) , 2071-2079
Abstract
Background: The natural history of peridevice leak (PDL) following left atrial appendage occlusion (LAAO) is unknown. This study sought to investigate changes of PDL from 2 until 12 months after LAAO, using cardiac computed tomography (CT), and to assess the potential association between persistent PDL and clinical outcomesMethods: Single‐center observational study of Amplatzer LAAO implants between 2010 and 2017 (n = 206). Patients with 2 and 12 months cardiac CT were included in the study (n = 153). Images were blindly analyzed. PDL was characterized by frequency and size at the device disc, lobe, and left atrial appendage contrast patency. Patients were followed for the composite outcome of ischemic stroke, transient ischemic attack, systemic embolism, or all‐cause death. Median follow up from LAAO was 3.1 (2.3–4.3) years.Results: Contrast patency was present in 101 (66%) and 72 (47%) (p < 0.001) at 2 and 12 months, respectively. PDL was identified at the disc in 103 (67%) patients at 2 months versus 93 (61%) at 12 months (p = 0.08), and at the lobe in 29 (19%) at both time points. PDL area at the disc did not change significantly over time, area: −8.95 mm (95% confidence interval [CI]: −18.9; 1.01) p = 0.08. Permanent atrial fibrillation was independently associated with persistent PDL. Persistent versus no PDL was associated with a 62% worse clinical outcome, however not statistically significant, hazard ratio (HR): 1.62 (95% CI: 0.9–2.93), p = 0.11.Conclusion: Persistent PDL was frequently observed following LAAO with Amplatzer devices. The PDL frequency and size appeared unchanged between 2 and 12 months. Persistent PDL was not significantly associated with worse clinical outcomes, yet this needs further delineation in future studies.Keywords
Funding Information
- Novo Nordisk Foundation Center for Basic Metabolic Research (NNF17OC0024868, NNF17OC0029510)
This publication has 30 references indexed in Scilit:
- Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapyEuroIntervention, 2017
- Cardiac Computed Tomography Angiography for Left Atrial Appendage ClosureCanadian Journal of Cardiology, 2016
- - LAA Occluder View for post-implantation Evaluation (LOVE) - standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomographyBMC Medical Imaging, 2016
- The Danish National Patient Registry: a review of content, data quality, and research potentialClinical Epidemiology, 2015
- Cardiac CT angiography for device surveillance after endovascular left atrial appendage closureEuropean Heart Journal - Cardiovascular Imaging, 2015
- Impact of Watchman and Amplatzer Devices on Left Atrial Appendage Adjacent Structures and Healing Response in a Canine ModelJACC: Cardiovascular Interventions, 2014
- Registration of acute stroke: validity in the Danish Stroke Registry and the Danish National Registry of PatientsClinical Epidemiology, 2013
- Registration of acute medical hospital admissions in the Danish National Patient Registry: a validation studyClinical Epidemiology, 2013
- The Clinical Impact of Incomplete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial FibrillationJACC, 2012
- Left Atrial Appendage ObliterationJACC: Cardiovascular Interventions, 2010